Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer

Ugo De Giorgi, Michal Mego, Eric M. Rohren, Ping Liu, Beverly C. Handy, James M. Reuben, Homer A. Macapinlac, Gabriel N. Hortobagyi, Massimo Cristofanilli and Naoto T. Ueno
Journal of Nuclear Medicine August 2010, 51 (8) 1213-1218; DOI: https://doi.org/10.2967/jnumed.110.076455
Ugo De Giorgi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michal Mego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric M. Rohren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ping Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverly C. Handy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M. Reuben
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Homer A. Macapinlac
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel N. Hortobagyi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Cristofanilli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoto T. Ueno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 8 1213-1218
DOI 
https://doi.org/10.2967/jnumed.110.076455
PubMed 
20660382

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 17, 2010
  • Accepted for publication April 20, 2010
  • Published online August 2, 2010.

Article Versions

  • previous version (July 21, 2010 - 13:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2010 by Society of Nuclear Medicine

Author Information

  1. Ugo De Giorgi1–3,
  2. Michal Mego1,2,
  3. Eric M. Rohren4,
  4. Ping Liu5,
  5. Beverly C. Handy6,
  6. James M. Reuben2,
  7. Homer A. Macapinlac4,
  8. Gabriel N. Hortobagyi1,
  9. Massimo Cristofanilli1 and
  10. Naoto T. Ueno1,7
  1. 1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  2. 2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  3. 3Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
  4. 4Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
  5. 5Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
  6. 6Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
  7. 7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
  1. For correspondence or reprints contact: Naoto T. Ueno, Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. E-mail: nueno{at}mdanderson.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 57 Citations
  • 53 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group
    Isabelle Thibault, Eric L Chang, Jason Sheehan, Manmeet S Ahluwalia, Matthias Guckenberger, Moon-Jun Sohn, Samuel Ryu, Matthew Foote, Simon S Lo, Alexander Muacevic, Scott G Soltys, Samuel Chao, Peter Gerszten, Eric Lis, Eugene Yu, Mark Bilsky, Charles Fisher, David Schiff, Michael G Fehlings, Lijun Ma, Susan Chang, Edward Chow, Wendy R Parelukar, Michael A Vogelbaum, Arjun Sahgal
    The Lancet Oncology 2015 16 16
  • Future cancer research priorities in the USA: a Lancet Oncology Commission
    Elizabeth M Jaffee, Chi Van Dang, David B Agus, Brian M Alexander, Kenneth C Anderson, Alan Ashworth, Anna D Barker, Roshan Bastani, Sangeeta Bhatia, Jeffrey A Bluestone, Otis Brawley, Atul J Butte, Daniel G Coit, Nancy E Davidson, Mark Davis, Ronald A DePinho, Robert B Diasio, Giulio Draetta, A Lindsay Frazier, Andrew Futreal, Sam S Gambhir, Patricia A Ganz, Levi Garraway, Stanton Gerson, Sumit Gupta, James Heath, Ruth I Hoffman, Cliff Hudis, Chanita Hughes-Halbert, Ramy Ibrahim, Hossein Jadvar, Brian Kavanagh, Rick Kittles, Quynh-Thu Le, Scott M Lippman, David Mankoff, Elaine R Mardis, Deborah K Mayer, Kelly McMasters, Neal J Meropol, Beverly Mitchell, Peter Naredi, Dean Ornish, Timothy M Pawlik, Jeffrey Peppercorn, Martin G Pomper, Derek Raghavan, Christine Ritchie, Sally W Schwarz, Richard Sullivan, Richard Wahl, Jedd D Wolchok, Sandra L Wong, Alfred Yung
    The Lancet Oncology 2017 18 11
  • Breast Cancer Metastasis and Drug Resistance
    Rie K. Tahara, Takae M. Brewer, Richard L. Theriault, Naoto T. Ueno
    2019 1152
  • Therapy monitoring of skeletal metastases with whole-body diffusion MRI
    Anwar R. Padhani, Andreas Makris, Peter Gall, David J. Collins, Nina Tunariu, Johann S. de Bono
    Journal of Magnetic Resonance Imaging 2014 39 5
  • Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
    Ugo De Giorgi, Paola Caroli, Salvatore L. Burgio, Cecilia Menna, Vincenza Conteduca, Emanuela Bianchi, Francesca Fabbri, Elisa Carretta, Dino Amadori, Giovanni Paganelli, Federica Matteucci
    Oncotarget 2014 5 23
  • Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
    Gary J.R. Cook, Gurdip K. Azad, Vicky Goh
    Journal of Nuclear Medicine 2016 57 Supplement 1
  • Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from Blood
    Andrew D Hughes, Jeff Mattison, Laura T Western, John D Powderly, Bryan T Greene, Michael R King
    Clinical Chemistry 2012 58 5
  • MRI for response assessment in metastatic bone disease
    F. E. Lecouvet, A. Larbi, V. Pasoglou, P. Omoumi, B. Tombal, N. Michoux, J. Malghem, R. Lhommel, B. C. Vande Berg
    European Radiology 2013 23 7
  • 18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer
    Alexander R. Haug, Beauclair P. Tiega Donfack, Christoph Trumm, Christoph J. Zech, Marlies Michl, Rüdiger Paul Laubender, Christopher Uebleis, Peter Bartenstein, Volker Heinemann, Marcus Hacker
    Journal of Nuclear Medicine 2012 53 3
  • Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
    Ugo De Giorgi, Michal Mego, Emanuela Scarpi, Mario Giuliano, Antonio Giordano, James M. Reuben, Vicente Valero, Naoto T. Ueno, Gabriel N. Hortobagyi, Massimo Cristofanilli
    Clinical Breast Cancer 2012 12 4

Article usage

Article usage: July 2010 to April 2025

AbstractFullPdf
Jul 201098016
Aug 201024454168
Sep 2010614364
Oct 2010362234
Nov 2010392434
Dec 2010251111
Jan 2011291013
Feb 2011203239
Mar 2011184149
Apr 2011153531
May 2011103125
Jun 2011812225
Jul 2011513333
Aug 2011733354
Sep 2011813540
Oct 2011592932
Nov 2011714432
Dec 2011671639
Jan 2012702037
Feb 2012522224
Mar 2012572633
Apr 2012662639
May 2012613034
Jun 2012591937
Jul 2012452225
Aug 2012411624
Sep 2012391118
Oct 2012481425
Nov 2012441122
Dec 2012421224
Jan 2013331917
Feb 2013341918
Mar 2013321120
Apr 201340816
May 2013621619
Jun 2013501614
Jul 201341816
Aug 2013261212
Sep 2013291314
Oct 20131738
Nov 2013521621
Dec 201322513
Jan 201426614
Feb 201430716
Mar 2014301434
Apr 201439422
May 2014391727
Jun 201421619
Jul 201432925
Aug 201411712
Sep 2014251224
Oct 2014281514
Nov 20142979
Dec 20141258
Jan 2015371515
Feb 20152699
Mar 201553810
Apr 2015251110
May 20154668
Jun 201519127
Jul 2015192119
Aug 20152096
Sep 20152585
Oct 20151099
Nov 20152487
Dec 2015661210
Jan 2016271512
Feb 20161756
Mar 20162458
Apr 2016151118
May 20168811
Jun 2016211512
Jul 20162295
Aug 20161976
Sep 20161696
Oct 2016171422
Nov 20168108
Dec 201617209
Jan 20171484
Feb 20177226
Mar 201723157
Apr 201710223
May 2017171312
Jun 201714105
Jul 20171394
Aug 20172095
Sep 201713134
Oct 20171475
Nov 20171464
Dec 2017693
Jan 20188914
Feb 20181173
Mar 20188169
Apr 20181263
May 201814116
Jun 201822112
Jul 201811125
Aug 20189911
Sep 20181364
Oct 201814155
Nov 20181753
Dec 20188154
Jan 201920154
Feb 201929194
Mar 201933198
Apr 201925104
May 20191026
Jun 20191235
Jul 2019231610
Aug 20191556
Sep 2019721
Oct 2019615
Nov 2019403
Dec 2019415
Jan 2020864
Feb 202010510
Mar 2020222
Apr 2020825
May 2020956
Jun 2020402
Jul 2020500
Aug 2020313
Sep 2020525
Oct 2020856
Nov 202018312
Dec 20205712
Jan 2021179
Feb 20212159
Mar 20215146
Apr 202151012
May 20214105
Jun 20216115
Jul 202151016
Aug 20212125
Sep 2021046
Oct 20212820
Nov 20215718
Dec 20210298
Jan 202235412
Feb 202224512
Mar 202204010
Apr 20222224
May 202202520
Jun 20224136
Jul 20220204
Aug 202231610
Sep 202211510
Oct 2022299
Nov 20225277
Dec 20221103
Jan 2023133114
Feb 20232123
Mar 202331117
Apr 20230147
May 202341016
Jun 2023091
Jul 20233811
Aug 20235912
Sep 20232306
Oct 20232339
Nov 2023199
Dec 20231285
Jan 20245268
Feb 20241489
Mar 2024313103
Apr 2024439515
May 202414615
Jun 20244209
Jul 202432118
Aug 202454011
Sep 202422314
Oct 20243257
Nov 2024289
Dec 202412116
Jan 202511410
Feb 20250618
Mar 2025205513
Apr 202533021
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (8)
Journal of Nuclear Medicine
Vol. 51, Issue 8
August 1, 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer
Ugo De Giorgi, Michal Mego, Eric M. Rohren, Ping Liu, Beverly C. Handy, James M. Reuben, Homer A. Macapinlac, Gabriel N. Hortobagyi, Massimo Cristofanilli, Naoto T. Ueno
Journal of Nuclear Medicine Aug 2010, 51 (8) 1213-1218; DOI: 10.2967/jnumed.110.076455

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer
Ugo De Giorgi, Michal Mego, Eric M. Rohren, Ping Liu, Beverly C. Handy, James M. Reuben, Homer A. Macapinlac, Gabriel N. Hortobagyi, Massimo Cristofanilli, Naoto T. Ueno
Journal of Nuclear Medicine Aug 2010, 51 (8) 1213-1218; DOI: 10.2967/jnumed.110.076455
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
  • Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer
  • Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer: 18F-FDG PET/CT Study
  • Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
  • Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from Blood
  • 18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer
  • Circulating Tumor Cells and PET
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire